Article Information
History
- March 15, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Xiaosong Li1,*,
- Pai Peng2,3,*,
- Haijun Deng2,3,*,
- Qian Yang1,
- Shi Chen1,
- Benhua Li1,
- Miao He4,
- Zhu Yang5,
- Ni Tang2,3,# and
- Ailong Huang2,3,#
- 1Clinical Molecular Medicine Testing Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
- 2Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Department of Infectious Diseases, Chongqing Medical University, Chongqing, China
- 3Institute for Viral Hepatitis, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
- 4Laboratory Animal Center of Chongqing Medical University, Chongqing, China
- 5Department of Gynecology and Obstetrics, the Second Affiliated Hospital of Chongqing Medical University
- ↵#Correspondence: Ai-long Huang (ahuang{at}cqmu.edu.cn) and Ni Tang (nitang{at}cqmu.edu.cn)
Posted March 15, 2023.
The real-world effectiveness of an intranasal spray A8G6 antibody cocktail in the post-exposure prophylaxis of COVID-19
